ABL1 and leukemia: In particular, sample leukemia stem cells from patient 12 (Figure 8), who had imatinib‐resistant ALL bearing multiple mutations, including T315I, were isolated by CD34‐positive sorting and treated with a single dose of PMIBcr/Abl‐R6 for 24 h.